Biotesserae Camunity
Corvallis
About Biotesserae Camunity
Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer. The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $100.0K
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2022)
- Website: biotesserae.com
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Canonical: https://fsome.com/organization/biotesserae-camunity-193840 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.